NewLimit is using epigenetic reprogramming to bring cells back to a younger and healthier state, thus tackling age related disease

Co-Founder & President Jacob Kimmel describes the science behind how this works, and the enormous amount of work that goes into choosing which transcription factors to target. The company is currently in IND enabling studies.

Episode metadata supplied by the publisher feed · Published Feb 19, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

NewLimit is using epigenetic reprogramming to bring cells back to a younger and healthier state, thus tackling age related disease

0:00 11:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BiotechTV - News?

This episode is 11 minutes long.

When was this BiotechTV - News episode published?

This episode was published on February 19, 2026.

Can I download this BiotechTV - News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!